Showing 7851-7860 of 9449 results for "".
Scientifically Speaking: Optimizing Results with PRP
https://practicaldermatology.com/videos/scientifically-speaking/scientifically-speaking-optimizing-results-with-prp/20034/As increasing evidence shows the benefits of PRP for hair loss, more practices are adding it to their menu. But the results of treatment can vary depending on numerous factors. Glynis Ablon, MD and Jeffrey Rapaport, MD talk to host Joel L. Cohen, MD about their approach and share expert tips to optiScientifically Speaking: The Expanded Role for Microneedling
https://practicaldermatology.com/videos/scientifically-speaking/the-expanded-role-for-microneedling/20011/What's the role for microneedling in today's practice? What are the best strategies to optimize outcomes? In this edition of Scientifically Speaking, host Joel L. Cohen, MD gathers expert insights from Anna Guanche, MD; Mara Weinstein Velez, MD; and Doris Day, MD.Scientifically Speaking: Diagnosing and Treating Hair Loss, Part 2
https://practicaldermatology.com/videos/scientifically-speaking/scientifically-speaking-diagnosing-and-treating-hair-loss-part-2/19958/From PRP to surgical updates and long-standing interventions, there are many options to address hair loss. It's essential to know the risks and benefits of treatments, including combinations. Host Joel L. Cohen, MD discusses options for hair loss with Marc Avram, MD, Cheryl Burgess, MD, and ReenDermWireTV: 2020 in Review
https://practicaldermatology.com/topics/psoriasis/dermwiretv-2020-in-review/19882/Crisaborole ointment became the first and only steroid-free, topical prescription medication for mild to moderate AD in patients as young as three months of age. Ustekinumab is approved for pediatric patients with moderate to severe plaque psoriasis. FDA approved ixekizumab injection, 80mg/mL for tPsoriasis Comorbidities
https://practicaldermatology.com/topics/psoriasis/psoriasis-comorbidities/19729/Do you assess the gums of patients with psoriasis? Joel Gelfand, MD explains why periodontal disease may be underappreciated for what it contributes to the psoriatic disease process.Modifying Masseters and More
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/modifying-masseters-and-more/19698/Artful use of neurotoxin in the masseters and parotid glands can help thin the appearance of the face. Chytra Anand, MD discusses her approach and talks about treatments used in her home country of India.Psoriasis Risk Factors and Comorbidities
https://practicaldermatology.com/topics/psoriasis/psoriasis-risk-factors-and-comorbidities/19650/Ronald Prussick, MD outlines known risk factors for developing psoriasis, such as genetic factors, smoking, alcohol consumption, and increased BMI, and recent studies that confirm these risks. He also shares data on comorbidities, including the patients with psoriasis are more prone to pathologic frBeautiFill™: One Step Fat Transfer Solution
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/beautifill-one-step-fat-transfer-solution/19550/Sponsored by AlmaNew Toxin Textbook Hits Shelves
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-toxin-textbook-hits-shelves/18321/Available at Wiley-Blackwell and on Amazon.com, “Botulinum Toxins: Cosmetic and Clinical Applications” offers up-to-date info on neuromodulators in the US and abroad, along with tips on how to use them on the face and body. Joel Cohen, MD shares details about his new textbook.Updates from CSF 2017
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-updates-from-csf-2017/18371/Dermatologists and core cosmetic physicians shared new insights and reviewed the developments in clinical and cosmetic dermatology at the ninth annual Cosmetic Surgery Forum in Las Vegas. Matthew Zirwas, MD addressed interest in oral supplements to support skin health. Neurotoxin pioneer Nick Lowe,